The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and commercialization When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea Is BPC 157 Legal? Understanding Its Status and Implications